<DOC>
	<DOCNO>NCT01267864</DOCNO>
	<brief_summary>This randomize study test 3 different intravenous medication see one best acute migraine . The three medication metoclopramide , valproate , ketorolac .</brief_summary>
	<brief_title>A Randomized Trial Valproate Versus Ketorolac Versus Metoclopramide Acute Migraine</brief_title>
	<detailed_description>One million patient present US emergency department ( ED ) annually treatment acute migraine headache . A variety parenteral medication use treat acute migraine , none offer rapid complete headache relief without side effect . Preliminary study suggest intravenous valproate , anti-epileptic medication establish efficacy migraine preventive , may useful treatment acute migraine . We propose randomize , comparative efficacy trial intravenous valproate compare two standard parenteral therapy acute migraine . There placebo control . Included subject adults 64 year young meet International Headache Society criterion acute migraine , clinical evidence secondary ( organic ) headache , allergy contra-indication investigational medication . The investigational medication 1gm valproate , 10mg metoclopramide , 30mg ketorolac . Patients approached participation randomize time presentation ED . Pain assess 11 point ( 0 10 ) verbal pain scale , validate use acute pain trial . Medication infuse slow intravenous drip . The primary outcome improvement headache intensity one hour initiation intravenous drip . Secondary outcome include assessment pain , functional disability , adverse event , satisfaction investigational medication one , two 24 hour initiation intravenous drip . The primary analysis use Student 's t-test independent sample involve three pair-wise comparison . Using alpha .017 ( account three pairwise comparison ) , standard beta , validate minimum clinically significant difference verbal pain scale , calculate need 330 subject . An interim analysis conduct determine lack efficacy valproate .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>IHS migraine without aura IHS probable migraine ( migraine without arua criterion must meet except duration may &gt; 72 hour &lt; 4 hour ) Allergy contraindication investigational medication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>migraine</keyword>
	<keyword>emergency</keyword>
	<keyword>metoclopramide</keyword>
	<keyword>ketorolac</keyword>
	<keyword>valproate</keyword>
</DOC>